| Anacor and Medicis in US$160 M Acne Research Pact |
Abstract
|
|
Heather Cartwright |
|
| Astellas Licenses Regional Rights to Optimer Pharmaceuticals’ Antibiotic for Clostridium Difficile Infection |
Abstract
|
|
Heather Cartwright |
|
| Progenics Licenses Relistor® to Salix Outside of Japan |
Abstract
|
|
Heather Cartwright |
|
| Novartis Advances its Capabilities in Personalised Medicine with Genoptix Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Amgen Signs Billion-Dollar Deal to Acquire BioVex for its Oncolytic Vaccine |
Abstract
|
|
Heather Cartwright |
|
| Alexion Pharmaceuticals Boosts its Rare Disease Pipeline with Taligen Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Valeant to Acquire PharmaSwiss and Expand its Presence in Central and Eastern Europe |
Abstract
|
|
Heather Cartwright |
|
| AdventRx Acquires SynthRx for Late-Stage Sickle Cell Disease Drug |
Abstract
|
|
Heather Cartwright |
|
| Allergan and MAP Pharmaceuticals Sign Co-Promotion Deal for Acute Migraine Treatment |
Abstract
|
|
Heather Cartwright |
|
| ANNUAL REVIEW: Deal Making in 2010 |
Abstract
|
|
Heather Cartwright |
|